Information packages will be sent by mail to study participants. The packages will include information about sleeping pills and other ways to get a good night’s sleep. The effect of the information packages on how sleeping problems are managed will be tested.
Respond to each of the following three questions to determine if you might be eligible to participate.
Do you regularly take one of the following medications for sleep?
Zopiclone (Immovane)
Lorazepam (Ativan)
Clonazepam (Rivotril)
Alprazolam (Xanax)
Temazepam (Restoril)
Chlordiazepoxide (Librium)
Diazepam (Valium)
Triazolam (Halcion)
Zolpidem (Sublinox)
Eszopiclone (Lunesta)
Bromazepam (Lectopam)
Oxazepam (Serax)
Flurazepam (Dalmane)
Nitrazepam (Mogadon)
You may be eligible to participate in the study.
Learn more about YAWNS NB and how to participate.
To be eligible, you must respond “Yes” to all 3 questions.
Please share the following information with others who may be interested in participating:
Once you know that you may be eligible to participate, the next step is to speak with a member of the research team to complete the screening process. You will be asked a few more specific questions to determine your eligibility.
Read the rest of the information provided here and then contact the research team.
As a study participant, you will speak with a researcher on the telephone on 2 occasions. The first interview happens a few days after you enrol in the study and the second takes place 6 months later. There are no in-person visits.
Each of the 2 interviews takes approximately 60 minutes to complete. Interview time can be made shorter by responding to some questions online rather than over the telephone.
The study is for residents of New Brunswick who are 65 years of age or older that regularly take sleeping pills. This study is specifically inviting people who take one of the following medications for sleep:
Zopiclone (Immovane)
Lorazepam (Ativan)
Clonazepam (Rivotril)
Alprazolam (Xanax)
Bromazepam (Lectopam)
Chlordiazepoxide (Librium)
Diazepam (Valium)
Triazolam (Halcion)
Zolpidem (Sublinox)
Eszopiclone (Lunesta)
Bromazepam (Lectopam)
Oxazepam (Serax)
Flurazepam (Dalmane)
Nitrazepam (Mogadon)
A team of researchers from Dalhousie University, University of New Brunswick, and University of Montreal are conducting the study.
Register your interest for the YAWNS NB study here. You will be contacted by telephone by Kamilla or Norma who will complete the study screening questionnaire with you. If you are eligible to participate, the next step is to complete the study consent form with the research team to enrol in the study.
Please provide your contact details and then click send.
You can also call the research staff:
Kamilla, Research Coordinator
Norma, Research Assistant
